Lewis, James H.

Drug-induced liver injury risk factors and drug development in DILI / [electronic resource] : Title from title frames Drug-induced liver injury : where we have been and where we are headed. Part 2 of 3, Risk factors and drug development in DILI James H. Lewis. - London : Henry Stewart Talks, 2021. - 1 online resource (1 streaming video file (26 min.) : color, sound). - Gastroenterology and hepatology : pathophysiology, presentation, diagnosis and management, 2056-452X Periodic reports : advances in clinical interventions and research platforms, 2056-452X . - Henry Stewart talks. Biomedical & life sciences collection. Gastroenterology and hepatology. Henry Stewart talks. Biomedical & life sciences collection. Periodic reports. .

Animated audio-visual presentation with synchronized narration. Title from publisher's web site. Updated version of a talk first published in 2011.

Contents: DILI risk factors -- Racial differences in DILI -- Statin use -- Drug metabolism -- Genetic risk factors for DILI -- Outcomes for DILI -- Regulatory science -- Hy's law and eDISH.

Access restricted to subscribers.


Mode of access: World Wide Web.

5496 Henry Stewart Talks


Drugs--Side effects.
Hepatotoxicology.
Liver--Diseases--Etiology.
Liver--Effect of drugs on.
Chemical and Drug Induced Liver Injury--etiology.
Chemical and Drug Induced Liver Injury--genetics.
Drug Approval.
Drug Development.
Drug-Related Side Effects and Adverse Reactions.
Hydroxymethylglutaryl-CoA Reductase Inhibitors.
Liver--drug effects.
Metabolic Clearance Rate.
Pharmacogenetics.
Risk Factors.
Technical University of Mombasa
Tom Mboya Street, Tudor 90420-80100 , Mombasa Kenya
Tel: (254)41-2492222/3 Fax: 2490571